24 Mar. 2022 18:00
2021 Annual results (before market)
Total Group Sales: €521 million (up 21.9% as reported) Annual Sale of Essential products: €296...
January 2022
Felpreva® (tigolaner/emodepside/praziquantel) has been granted marketing authorisation by the...
November 2021
Regarding dissolution of Vetoquinol Zenoaq Co., Ltd and establishment of Vetoquinol Japan Co., Ltd
Vetoquinol (Headquarters: Lure, France, CEO: Matthieu Frechin, hereafter Vetoquinol) and Nippon...
October 2021
Third quarter revenues: €132 million +14.3% at constant exchange rates
Third quarter sales of Essential products: €75 million +26.0% at constant exchange rates Vetoquinol...
October 2021
Vetoquinol UK achieves bronze accreditation with Investors in the Environment
Veterinary pharmaceuticals company, Vetoquinol UK, has achieved bronze accreditation with Investors...
October 2021
We are pleased to announce that the Committee for Medicinal Products for Veterinary Use (CVMP) has...
September 2021
STRONG PERFORMANCE ACROSS THE BOARD First half sales: €255m (up 33.5% at constant exchange rates)...
July 2021
Innovation - New light therapy supports skin recovery in pets
For faster skin recovery in dogs and cats, Vetoquinol has just introduced mid-May in the first...
June 2021
